We'll resume the meeting now.
Welcome, everyone, as we resume meeting number 16 of the House of Commons Standing Committee on Health. We are meeting today to study the emergency situation facing Canadians in light of the second wave of the COVID-19 pandemic.
As we welcome our new panel, I would like to point out to the witnesses that they may speak in the official language of their choice. Interpretation services are available for the meeting. You have a choice at the bottom of your screen of “floor”, “English” or “French”.
With that, I will go through the list of witnesses. We have Dr. Joel Lexchin, medical doctor, appearing as an individual; from the Canadian Public Health Association, we have Mr. Ian Culbert, executive director; with the COVID-19 Immunity Task Force, we have Mr. Timothy Evans, executive director. From Medicago Incorporated, we have Ms. Nathalie Landry, executive vice-president, scientific and medical affairs; and we have Mr. Nicolas Petit, vice-president, commercial operations.
We'll start with Dr. Lexchin. Welcome, and please go ahead, sir. You have six minutes.